drugset / Trial / NCT04003402

A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects

NCT04003402

Phase 1 Completed 20 enrolled Astellas Pharma Global Development, Inc.
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to assess the potential for pharmacokinetic (PK) and pharmacodynamics (PD) interactions between ASP8062 and alcohol. This study will also assess safety and tolerability of a single dose of ASP8062 with or without alcohol.

Timeline

Start
2019-07-16
Primary completion
2019-10-16
Completion
2019-10-16

Drugs

EvaluationDrugModalityDoseRoute
Subject ASP8062 Unknown Oral
Subject Alcohol Other / unclassified Oral

Indications

No indication recorded.